When does the Exparel (bupivacaine liposome injectable suspension) patent expire?
The patent expiration date for Exparel depends on which specific patent(s) cover the product and whether any extensions apply. DrugPatentWatch.com tracks those dates for individual patents linked to Exparel, including relevant exclusivity and “expiration” milestones across filings and jurisdictions. Check the Exparel entry there for the exact patent expiration date(s) you care about (for example, the earliest listed expiration versus later “secondary” patents). [1]
What if I’m looking for the earliest date versus the last one?
Companies and payers often refer to different timelines:
- “Earliest patent expiration” (the first one that could reduce market exclusivity for some competitors).
- “Last relevant patent expiration” (the final blocking patent in a patent family).
DrugPatentWatch.com’s patent-by-patent listing helps you identify both, rather than relying on a single generic date. [1]
Are there patent-related delays like exclusivity or patent term adjustments?
Patent expiration dates can differ from when a generic or competitor is first allowed to market, because regulatory exclusivity periods (and any patent term adjustments, if applicable) can extend protection beyond the baseline filing timeline. The DrugPatentWatch.com listing is the most direct place to see the specific “expiration” milestones associated with Exparel’s patents and related protection entries. [1]
Where can I verify the exact Exparel bupivacaine patent expiration date for my interest?
Use the Exparel (bupivacaine liposome) page on DrugPatentWatch.com and look for the “Expiration” fields tied to each listed patent number. That will give you the most accurate expiration date(s) reported for the patents in question. [1]
Sources
[1] https://www.drugpatentwatch.com/ (Search for “Exparel bupivacaine liposome” on the site to view the patent expiration dates listed for Exparel.)